Cargando…
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India
BACKGROUND & OBJECTIVES: Healthcare workers (HCWs) are considered to be at a high risk of contracting COVID-19 infection. Besides, control of nosocomial infections transmitted from HCWs to the patients is also a cause of concern. This study was undertaken to investigate the seroprevalence of ant...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184075/ https://www.ncbi.nlm.nih.gov/pubmed/33642348 http://dx.doi.org/10.4103/ijmr.IJMR_3911_20 |
_version_ | 1783704515405414400 |
---|---|
author | Gupta, Ritu Dwivedi, Tanima Gajendra, Smeeta Sahoo, Biswajeet Gupta, Sanjeev Kumar Vikas, H. Singh, Angel Rajan Mohan, Anant Bhatnagar, Sushma Singh, Sheetal Wundavalli, Laxmitej Guleria, Randeep |
author_facet | Gupta, Ritu Dwivedi, Tanima Gajendra, Smeeta Sahoo, Biswajeet Gupta, Sanjeev Kumar Vikas, H. Singh, Angel Rajan Mohan, Anant Bhatnagar, Sushma Singh, Sheetal Wundavalli, Laxmitej Guleria, Randeep |
author_sort | Gupta, Ritu |
collection | PubMed |
description | BACKGROUND & OBJECTIVES: Healthcare workers (HCWs) are considered to be at a high risk of contracting COVID-19 infection. Besides, control of nosocomial infections transmitted from HCWs to the patients is also a cause of concern. This study was undertaken to investigate the seroprevalence of antibodies against the SARS-CoV-2 virus among the hospital staff of a tertiary care health facility in north India. METHODS: The HCWs were tested for SARS-CoV-2 serology (IgG+IgM) using chemiluminescence immunoassay between June 22 and July 24, 2020. Venous blood (2 ml) was collected and tested for SARS-CoV-2 IgG and IgM antibodies. RESULTS: Of the 3739 HCWs tested, 487 (13%) were positive for total SARS-CoV-2 antibodies. The highest seroprevalence was observed in administrative staff (19.6%) and least in physicians (5.4%). The staff who used public (20%) and hospital transportation (16.9%) showed higher seroprevalence compared to staff using personal transportation (12.4%). No difference was observed between HCWs posted in COVID versus non-COVID areas. All seropositive symptomatic HCWs in our study (53.6%) had mild symptoms, and the remaining 46.4 per cent were asymptomatic. The antibody positivity rate progressively increased from 7.0 per cent in the first week to 18.6 per cent in the fourth week during the study. INTERPRETATION & CONCLUSIONS: The presence of antibodies to SARS-CoV-2 in a significant number of asymptomatic HCWs, association with the use of public transport, relatively lower seroprevalence compared with the non-HCWs and rising trend during the period of the study highlight the need for serosurveillance, creating awareness for infection control practices including social distancing and study of infection dynamics in the community for effective control of an infectious pandemic. |
format | Online Article Text |
id | pubmed-8184075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-81840752021-06-21 Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India Gupta, Ritu Dwivedi, Tanima Gajendra, Smeeta Sahoo, Biswajeet Gupta, Sanjeev Kumar Vikas, H. Singh, Angel Rajan Mohan, Anant Bhatnagar, Sushma Singh, Sheetal Wundavalli, Laxmitej Guleria, Randeep Indian J Med Res Policy BACKGROUND & OBJECTIVES: Healthcare workers (HCWs) are considered to be at a high risk of contracting COVID-19 infection. Besides, control of nosocomial infections transmitted from HCWs to the patients is also a cause of concern. This study was undertaken to investigate the seroprevalence of antibodies against the SARS-CoV-2 virus among the hospital staff of a tertiary care health facility in north India. METHODS: The HCWs were tested for SARS-CoV-2 serology (IgG+IgM) using chemiluminescence immunoassay between June 22 and July 24, 2020. Venous blood (2 ml) was collected and tested for SARS-CoV-2 IgG and IgM antibodies. RESULTS: Of the 3739 HCWs tested, 487 (13%) were positive for total SARS-CoV-2 antibodies. The highest seroprevalence was observed in administrative staff (19.6%) and least in physicians (5.4%). The staff who used public (20%) and hospital transportation (16.9%) showed higher seroprevalence compared to staff using personal transportation (12.4%). No difference was observed between HCWs posted in COVID versus non-COVID areas. All seropositive symptomatic HCWs in our study (53.6%) had mild symptoms, and the remaining 46.4 per cent were asymptomatic. The antibody positivity rate progressively increased from 7.0 per cent in the first week to 18.6 per cent in the fourth week during the study. INTERPRETATION & CONCLUSIONS: The presence of antibodies to SARS-CoV-2 in a significant number of asymptomatic HCWs, association with the use of public transport, relatively lower seroprevalence compared with the non-HCWs and rising trend during the period of the study highlight the need for serosurveillance, creating awareness for infection control practices including social distancing and study of infection dynamics in the community for effective control of an infectious pandemic. Wolters Kluwer - Medknow 2021 /pmc/articles/PMC8184075/ /pubmed/33642348 http://dx.doi.org/10.4103/ijmr.IJMR_3911_20 Text en Copyright: © 2021 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Policy Gupta, Ritu Dwivedi, Tanima Gajendra, Smeeta Sahoo, Biswajeet Gupta, Sanjeev Kumar Vikas, H. Singh, Angel Rajan Mohan, Anant Bhatnagar, Sushma Singh, Sheetal Wundavalli, Laxmitej Guleria, Randeep Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India |
title | Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India |
title_full | Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India |
title_fullStr | Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India |
title_full_unstemmed | Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India |
title_short | Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India |
title_sort | seroprevalence of antibodies to sars-cov-2 in healthcare workers & implications of infection control practice in india |
topic | Policy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184075/ https://www.ncbi.nlm.nih.gov/pubmed/33642348 http://dx.doi.org/10.4103/ijmr.IJMR_3911_20 |
work_keys_str_mv | AT guptaritu seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT dwiveditanima seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT gajendrasmeeta seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT sahoobiswajeet seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT guptasanjeevkumar seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT vikash seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT singhangelrajan seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT mohananant seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT bhatnagarsushma seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT singhsheetal seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT wundavallilaxmitej seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia AT guleriarandeep seroprevalenceofantibodiestosarscov2inhealthcareworkersimplicationsofinfectioncontrolpracticeinindia |